Biotech
Metsera
Metsera raises $215M Series B at $1.2B valuation
$215M
Total Raised
Series B
Latest Round
2022
Founded
100+
Employees
San Diego, CA
1 min read
Quick Facts
Valuation
$1.2B
Latest Round Size
$215M
Latest Round Date
November 2024
Metsera: Series B Funding Round
Metsera has successfully raised $215M in Series B funding, reaching a valuation of $1.2B.
Company Overview
Obesity and metabolic disease therapies
Funding Details
The Series B round was led by Venrock Healthcare Capital Partners, with participation from Wellington Management.
Company Information
- Headquarters: San Diego, CA
- Founded: 2022
- Employees: 100+
- Category: Biotech
Investment
Metsera plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Venrock Healthcare Capital Partners: Verified investor in Series B
- Wellington Management: Verified investor in Series B
Key Investors
Venrock Healthcare Capital Partners
Lead Investor
Verified investor in Series B
Wellington Management
Investor
Verified investor in Series B
About the Author
Editorial Team
Curated funding news from verified sources
Related Company Reports
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Biotech
Vir Biotechnology
Vir Biotechnology Raises $250M
Clinical-stage immunology company developing treatments for infectious diseases including COVID-19, hepatitis B, and influenza
Sarah Kim
Oct 23, 2025
0 min read•$250M